Author:
Krishna Gopal,Ma Lei,Martinho Monika,Prasad Pratapa,Wahl Janice,Tavakkol Amir
Abstract
ABSTRACTPharmacokinetic data from a randomized, parallel-group, multicenter study are presented. Adults with toenail onychomycosis (n= 146) received posaconazole (100 mg, 200 mg, or 400 mg) once daily (QD) for 24 weeks or 400 mg QD for 12 weeks. The posaconazole concentration in the great toenail exhibited a dose-related increase starting at week 2 for 24 weeks and a mean toenail-to-plasma concentration ratio of approximately 3:1 at the end of treatment for the 400-mg 24-week dose.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献